Legal Opinion

In Re Glumetza Antitrust Litigation

District Court, N.D. California

Decided March 5, 2020No. 3:19-cv-05822Unknown

1Opinion

1 2 3 4 5 UNITED STATES DISTRICT COURT 6 NORTHERN DISTRICT OF CALIFORNIA 7 8 In re No. C 19-05822 WHA 9 GLUMETZA ANTITRUST No. C 19-05831 WHA LITIGATION. No. C 19-06138 WHA 10 No. C 19-06156 WHA No. C 19-06839 WHA 11 This Document Relates to: No. C 19-07843 WHA No. C 19-08155 WHA 12 ALL ACTIONS. No. C 20-01196 WHA No. C 20-01198 WHA 13 (Consolidated) 14 15 ORDER RE MOTIONS TO DISMISS 16 INTRODUCTION 17 In this antitrust action arising from an alleged reverse-payment settlement of a patent 18 infringement suit between brand and generic marketers of the diabetes drug Glumetza, 19 defendants…

2Cases cited50 opinions

  1. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  2. Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
  3. Erie Railroad v. TompkinsSupreme Court of the United States · 1938
  4. DaimlerChrysler Corp. v. CunoSupreme Court of the United States · 2006
  5. Bartlett v. StricklandSupreme Court of the United States · 2009

45 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API